Therapeutic options targeting angiogenesis in nonsmall cell lung cancer
There is a major unmet medical need for effective and well-tolerated treatment options for patients with advanced nonsmall cell lung cancer (NSCLC), in both first-line and relapsed/refractory settings. Experimental evidence has validated signalling pathways that regulate tumour angiogenesis, includi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2014-03-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/23/131/79.full.pdf+html |